Webinar: Conversation between a sponsor and a statistician about phase II/III trials in oncology
1:02:27
Why do so many phase III trials fail
58:26
Adaptive Trial Designs - Introduction for Non-Statisticians
1:02:39
Assessing treatment efficacy in early-phase oncology trials
59:17
Risk-Based Fraud Detection: How Centralized Monitoring Can Boost Data Quality
1:02:06
Does Real World Evidence have a role in Precision Oncology
1:01:05
Webinar: The Benefit-Risk assessment of new treatments: The Health Technology Assessment process
1:00:56
GPC - A novel statistical method for outcome analysis & reporting of prioritized composite endpoints
59:18